[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-340802-105":3,"detail-sidebar-cat-0-en-105":80,"doc-detail-340802-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":73,"head_meta":75,"extra_data":77,"updated_unix":79},105,"en","immuno-targeting-the-ectopic-phosphorylation-sites-of-pdgfra-generated-by-man2a1-fer-fusion-in-hcc","Immuno-targeting the ectopic phosphorylation sites of PDGFRA generated by MAN2A1-FER fusion in HCC","","HCC is a highly lethal cancer, and MAN2A1-FER is a frequent oncogenic fusion in HCC. The study demonstrates that MAN2A1-FER ectopically phosphorylates extracellular domains of PDGFRA and other transmembrane proteins, activating their kinase activities and downstream signaling cascades. Monoclonal antibodies were developed to bind PDGFRA phosphotyrosine epitopes with high affinity and specificity. Antibody 2-3B-G8 suppresses growth signaling, induces growth arrest and cell death in MAN2A1-FER–positive cells, and inhibits tumor progression and metastasis in xenograft models.",{"@graph":14,"@context":72},[15,34,55],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/immuno-targeting-the-ectopic-phosphorylation-sites-of-pdgfra-generated-by-man2a1-fer-fusion-in-hcc/340802/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/immuno-targeting-the-ectopic-phosphorylation-sites-of-pdgfra-generated-by-man2a1-fer-fusion-in-hcc/340802.png","ImageObject",300,407,{"name":42,"@type":43},"Ophelia","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":33},"InteractionCounter",{"@type":54},"ViewAction",{"@type":56,"mainEntity":57},"FAQPage",[58,64,68],{"name":59,"@type":60,"acceptedAnswer":61},"What role does MAN2A1-FER play in HCC according to the report?","Question",{"text":62,"@type":63},"MAN2A1-FER is described as a frequent oncogenic fusion in HCC that ectopically phosphorylates extracellular domains of PDGFRA and other transmembrane proteins, activating their kinase activities and downstream signaling.","Answer",{"name":65,"@type":60,"acceptedAnswer":66},"How were the target-specific antibodies created and what do they recognize?",{"text":67,"@type":63},"A panel of mouse monoclonal antibodies was developed to recognize ectopic phosphorylation sites of PDGFRA. The antibodies bind specific phosphotyrosine epitopes in the extracellular domain of PDGFRA with high affinity and specificity.",{"name":69,"@type":60,"acceptedAnswer":70},"What is the biological effect of the antibody 2-3B-G8 on cancer cells?",{"text":71,"@type":63},"Treatment of MAN2A1-FER–positive HUH7 cells with 2-3B-G8 deactivates growth signaling pathways and causes growth arrest, and it induces cell death in MAN2A1-FER–positive cancer cell lines while showing minimal impact on MAN2A1-FER–disrupted HUH7ko cells.","https://schema.org",{"og:url":32,"og:type":74,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":76,"canonical":32},"index,follow",{"doc_id":78,"site_id":7},340802,1791243401,{"code":4,"msg":81,"data":82},"success",[83,87,91,95,100,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":84,"show_sort_weight":85,"slug":86},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":88,"show_sort_weight":89,"slug":90},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":92,"show_sort_weight":93,"slug":94},"Exam",70,"exam",{"id":96,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},5,"Comic",60,"comic",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},6,"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":96,"slug":129},19,"General","general",{"code":4,"msg":81,"data":131},{"doc_id":78,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":33,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},7971461741311,"https://ap-avatar.wpscdn.com/avatar/74000253aff267980c6?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779345379180704826","Immuno-targeting the ectopic phosphorylation sites of PDGFRA generated by MAN2A1-FER fusion in HCC  \nVISUAL ABSTRACT  \nDOI: 10.1097/HC9.0000000000000511  \nO R IG INAL ART ICL E  \nImmuno-targeting the ectopic phosphorylation sites of PDGFRA generated by MAN2A1-FER fusion in HCC  \nMuhamuda Kader1 | Yan-Ping Yu1,2 | Silvia Liu1,2 | Jian-Hua Luo1,2   \n1Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA  \n2High Throughput Genome Center, Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA  \nCorrespondence  \nJian-Hua Luo, Department of Pathology, Scaife S-728, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA. Email: [luoj@upmc.edu](luoj@upmc.edu)  \n\n|  | Abstract |  |\n| --- | --- | --- |\n| | Background: HCC is one of the most lethal cancers for humans. Mannosidase alpha class 2A member 1 (MAN2A1)-FER is one of the most frequent oncogenic fusion genes in HCC. In this report, we showed that MAN2A1-FER ectopically phosphorylated the extracellular domains of PDGFRA, MET, AXL, and N-cadherin. The ectopic phosphorylation of these transmembrane proteins led to the activation of their kinase activities and initiated the activation cascades of their downstream signaling molecules. Methods: A panel of mouse monoclonal antibodies was developed to recognize the ectopic phosphorylation sites of PDGFRA.\u003Cbr>Results and conclusions: The analyses showed that these antibodies bound to the specific phosphotyrosine epitopes in the extracellular domain of PDGFRA with high affinity and specificity. The treatment of MAN2A1-FER– positive cancer HUH7 with one of the antibodies called 2-3B-G8 led to the deactivation of cell growth signaling pathways and cell growth arrest while having minimal impact on HUH7ko cells where MAN2A1-FER expression was disrupted. The treatment of 2-3B-G8 antibody also led to a large number of cell deaths of MAN2A1-FER–positive cancer cells such as HUH7, HEPG2, SNU449, etc., while the same treatment had no impact on HUH7ko cells. When severe combined immunodeficiency mice xenografted with HEPG2 or HUH7 were treated with monomethyl auristatin E-conjugated 2-3B-G8 antibody, it slowed the progression of tumor growth, eliminated the metastasis, and reduced the mortality, in comparison with the controls. Targeting the cancer-specific ectopic phosphorylation sites of PDGFRA induced by MAN2A1-FER may hold promise as an effective treatment for liver cancer. |  |\n|  |  |  |\n\nAbbreviations: EGFR, epidermal growth factor receptor; MAN2A1, mannosidase alpha class 2A member 1; MMAE, monomethyl auristatin E; PDGFR, plateletderived growth factor receptor; SCID, severe combined immunodeficiency.  \nSupplemental Digital Content is available for this article. Direct URL citations are provided in the HTML and PDF versions of this article on the journal’s website, www.hepcommjournal.com.  \n-- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- -  \nThis is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.  \nCopyright © 2024 The Author(s) . Published by Wolters Kluwer Health, Inc. on behalf of the American Association for the Study of Liver Diseases.  \n2 | www. hepcommjournal.com Hepatology Communications. 2024;8:e0511  \nINTRODUCTION  \nLiver cancer is one of the most lethal human malignancies. Worldwide, 830,200 people died from primary liver cancers in 2020 . [1] It is expected the mortality of primary liver cancer will rise by more than 55% by 2040 . Among the primary liver cancers, HCC accounted for 90% of the liver cancer cases. [2] Currently, the main approach in treating primary liver cancer is surgical interventions,[2] either through liver transplantation or surgical resection. However, these option","cbCaigQI8wNtWPGs","https://ap.wps.com/l/cbCaigQI8wNtWPGs","pdf",1104518,15,"English","# Abstract\n# Introduction\n# Methods","[{\"question\":\"What role does MAN2A1-FER play in HCC according to the report?\",\"answer\":\"MAN2A1-FER is described as a frequent oncogenic fusion in HCC that ectopically phosphorylates extracellular domains of PDGFRA and other transmembrane proteins, activating their kinase activities and downstream signaling.\"},{\"question\":\"How were the target-specific antibodies created and what do they recognize?\",\"answer\":\"A panel of mouse monoclonal antibodies was developed to recognize ectopic phosphorylation sites of PDGFRA. The antibodies bind specific phosphotyrosine epitopes in the extracellular domain of PDGFRA with high affinity and specificity.\"},{\"question\":\"What is the biological effect of the antibody 2-3B-G8 on cancer cells?\",\"answer\":\"Treatment of MAN2A1-FER–positive HUH7 cells with 2-3B-G8 deactivates growth signaling pathways and causes growth arrest, and it induces cell death in MAN2A1-FER–positive cancer cell lines while showing minimal impact on MAN2A1-FER–disrupted HUH7ko cells.\"}]","Immuno-targeting the ectopic phosphorylation sites of PDGFRA generated by MAN2A1-FER fusion in HCC | PDF",1790038949,38,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/032c17a1c3b03e36c78cd5cde7073b4a.webp",983,1296,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8f7d0f1147ec65d12a80116d7a8ff50a.webp",982,1294,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/640646ff65d584f8a7f9452f730b6c77.webp",981,1293,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e92d8ffe423fb9fb28d2617b1f37b510.webp",980,1292]